Oncolytic Virus Therapy Market size was valued at USD 3.15 Billion in 2024 and is projected to reach USD 8.45 Billion by 2033, exhibiting a CAGR of 12.9% from 2026 to 2033.
In 2022, the global oncolytic virus therapy market was valued at approximately USD 120 million, with a compound annual growth rate (CAGR) of 26.7%. North America dominated the market, accounting for 42.1% of the global share, driven by a robust research infrastructure and early adoption of innovative therapies. The United States, in particular, contributed significantly, with a market value of USD 7.3 million in 2023 and an anticipated CAGR of 26.5%. Europe also held a substantial market share, with Germany emerging as a key player due to its increasing pre clinical research programs and dedicated cancer research facilities. The Asia Pacific region is poised for remarkable growth in the oncolytic virus therapy market. Factors such as a large patient population, increasing cancer prevalence, and supportive government initiatives are driving this expansion. India, for instance, is witnessing accelerated growth due to rising cancer cases and government efforts to enhance advanced cancer care capabilities. Additionally, the region benefits from a well established clinical research infrastructure, facilitating the development and availability of new oncolytic virotherapies. Overall, the global market is expected to reach USD 360 million by 2027, growing at a CAGR of 24.6%.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=78408&utm_source=Google_site_G_April&utm_medium=227
Â
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=78408&utm_source=Google_site_G_April&utm_medium=227
Growing demand for below applications around the world has had a direct impact on the growth of the Global Oncolytic Virus Therapy Market
Adenoviruses
Herpes Simplex Virus (HSV)
Reovirus
Vaccinia Virus
Newcastle Disease Virus (NDV)
Tumor Treatment
Oncolytic Immunotherapy
Combination Therapy (with chemotherapy/radiation)
Palliative Care
Intratumoral
Intravenous
Intraperitoneal
Intranasal
Intradermal
Hospitals
Research Laboratories
Specialty Clinics
Academic Institutions
Melanoma
Breast Cancer
Lung Cancer
Prostate Cancer
Head and Neck Cancers
Others (e.g., pancreatic, colorectal)
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/global-oncolytic-virus-therapy-market-growth-status-and-outlook-2019-2024/
1. Introduction of the Global Oncolytic Virus Therapy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Oncolytic Virus Therapy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Oncolytic Virus Therapy Market, By Type
6. Global Oncolytic Virus Therapy Market, By Application
7. Global Oncolytic Virus Therapy Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Oncolytic Virus Therapy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/